Meropenem Agmed

Meropenem, the active ingredient in Meropenem Agmed, is a carbapenem presented as an injection for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, septicemia and meningitis in hospitalized patients.

GNH USA supplies Meropenem Agmed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections.

- Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure in patients with intra‑abdominal sepsis. - Complicated urinary tract infections: achieves resolution of infection caused by susceptible Gram‑negative and Gram‑positive organisms. - Nosocomial pneumonia: facilitates recovery by targeting resistant pathogens in hospital‑acquired lung infections. - Septicemia: clears bloodstream infection caused by susceptible bacteria. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis.

Adverse reactions may occur with any intravenous antibiotic and should be monitored.

Common Side Effects: - Diarrhea: mild to moderate gastrointestinal upset. - Nausea: occasional feeling of queasiness. - Headache: transient cranial discomfort. - Infusion site phlebitis: redness or pain at the injection site.

Serious or Rare Side Effects: - Seizures: especially in patients with pre‑existing CNS disorders or high doses. - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile‑associated diarrhea: potentially life‑threatening colitis. - Renal impairment: worsening kidney function in susceptible individuals.

Careful assessment and monitoring are required before and during therapy.

- Renal function: adjust dosing or monitor closely in patients with impaired renal function. - Seizure risk: observe patients with central nervous system disorders or receiving high doses. - Allergy: avoid in individuals with known hypersensitivity to carbapenems or other β‑lactam antibiotics. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus (Category B). - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potential drug‑drug interactions should be evaluated to minimise toxicity.

Major Interactions (Avoid): - Valproic acid: may reduce serum levels, increasing seizure risk. - Cisplatin: combined use can heighten nephrotoxicity. - Probenecid: may raise meropenem concentrations, risking toxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: additive renal effects require monitoring of kidney function. - Aminoglycosides: synergistic antibacterial effect but may increase nephrotoxicity; renal function should be checked regularly.